The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Uramix sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Uramix Inc (Uramix) is a medical device company that offers tools and treatments in the field of urology. The company provides products such as original cavernotome, advanced cavernotome, double-bladed advanced cavernotome and stent removing snare. In addition, it also offers instrument cleaning services. Uramix identifies surgical technologies and tools to overcome technical problems in operative urology. The company products find applications in cuts and shaving fibrotic tissue in Peronie’s disease, sickle cell, priapism, prolonged intracavernosal therapy and subcapsular space creation in the eroded prosthesis. It also leases out the cavernotome set. Uramix is headquartered in Lansdowne, Pennsylvania, the US.
The key metrics of Uramix related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Uramix is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Uramix.
For a detailed understanding of the performance of Uramix, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
